Froese Grant discloses ownership in Helus Pharma Inc.
Froese Grant files Form 3, revealing ownership interests in Helus Pharma Inc., indicating potential strategic alignment in the pharmaceutical sector.
Kimberly A. Fields Files Form 3 as Director at L3Harris
Kimberly A. Fields has filed a Form 3 with the SEC, detailing her ownership in L3Harris Technologies, Inc., where she serves as a director.
Theresa Firestone discloses share ownership in Helus Pharma
Theresa Firestone reports ownership of 76,879 shares in Helus Pharma Inc., emphasizing her role as a director and influence in the pharmaceutical industry.
Helus Pharma reports director Mark Lawson's ownership change
Helus Pharma Inc. reveals director Mark Lawson's ownership of 160,026 shares, reflecting confidence in the company's future in pharmaceutical preparations.
Delli Paoli Michael Files Form 3 as Portfolio Manager
Delli Paoli Michael files Form 3, marking a change in ownership status as a portfolio manager at Rockefeller Multi Alternatives Portfolio.
JPMorgan Public & Private Income Fund reports officer change
Timothy J. Clemens files as an officer for JPMorgan Public & Private Income Fund, reflecting changes in leadership and governance within the investment sector.
Rockefeller Multi Alternatives Portfolio Reports Ownership Change
Rockefeller Multi Alternatives Portfolio files Form 3, indicating ownership changes by Rockefeller & Co. LLC as sub-adviser, impacting the investment sector.
JPMorgan Public & Private Income Fund names Glenn J. Hill CEO
JPMorgan Public & Private Income Fund announces Glenn J. Hill as its new CEO, marking a significant leadership change within the investment management sector.
Matheson Lee files ownership report, holds no securities
Matheson Lee's recent filing shows no ownership of securities in Mattel, reflecting a notable transparency in executive holdings.
Duanshi Chloe Tianyu files Form 3 as Portfolio Manager
Duanshi Chloe Tianyu files Form 3, revealing her role as Portfolio Manager at Rockefeller Multi Alternatives Portfolio, emphasizing governance and transparency.
Rockefeller Multi Alternatives Portfolio Updates Officer Ownership
Rockefeller Multi Alternatives Portfolio reports a change in officer ownership with Clark Casey Collins now listed, signaling potential strategic shifts.
Klaber Jacqueline Allison Reports Ownership Change in Portfolio
Klaber Jacqueline Allison files ownership report for Rockefeller Multi Alternatives Portfolio, indicating her role as a portfolio manager.
Bruns Christopher Reports 20,000 Shares in LGL Group Inc
Christopher Bruns, VP and Controller of LGL Group Inc, discloses ownership of 20,000 shares, including unvested restricted stock.
Wise Group plc reports ownership change by director Eilam Barak
Wise Group plc files Form 3, revealing Eilam Barak's ownership change, highlighting transparency in the business services sector.
Lycia Therapeutics reports new stock option for director
Lycia Therapeutics has filed a new ownership report indicating a stock option grant for director Jane Henderson, reflecting ongoing executive incentives.
John Carethers Files Form 3, Reports Share Ownership in AbbVie
John Carethers has filed a Form 3, indicating his ownership of shares in AbbVie Inc., highlighting compliance in the pharmaceutical industry.
Hastings Gregory S Reports Change in Neogen Corp Ownership
Hastings Gregory S reports a change in his ownership of Neogen Corp, indicating a direct ownership of 32,368 shares. This impacts corporate governance.
Fertitta Michael D files Form 3, shows no securities ownership
Michael D. Fertitta's recent Form 3 filing reveals no ownership of Smith & Wesson securities, impacting investor perceptions in the ordnance industry.
Health In Tech, Inc. CEO Discloses Share Ownership Update
Health In Tech, Inc. CEO Sanjay Shrestha reports ownership of 101,200 shares, emphasizing transparency in the insurance industry.
Lee Chin Hyok Reports New Stock Options at Lycia Therapeutics
Lee Chin Hyok, Chief Medical Officer at Lycia Therapeutics, reports new stock options, reflecting the company's commitment to executive compensation.